Stress Urinary Incontinence Panel. Marie Fidela R. Paraiso, M.D. Head, Division of Urogynecology Professor of Surgery Cleveland Clinic Lerner College of Medicine at Case Western Reserve University Cleveland, OH. What I Do Surgically For My Patients With SUI, cont’d. Situation Surgery.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Marie Fidela R. Paraiso, M.D.
Head, Division of Urogynecology
Professor of Surgery
Cleveland Clinic Lerner College of Medicine at
Case Western Reserve University
Primary or recurrent TVT or
SUI with hypermobility – TOT
older, LPP > 60
SUI with Stage 2 or 3 TOT
prolapse, vaginal repair
Recurrent SUI with “tight” TVT or
hypermobility – Rectus Fascia
LPP < 60 (ISD) Patch Sling
Recurrent SUI with Periurethral
Q-Tip < 30º; any bulking with
“Potential” SUI with TOT or Mini-sling prolapse reduced, with cystocele
vaginal repair repair
Office Procedures for Stress Urinary Incontinence: Bulking Agent Injections and Autologous Stem Cells
Stem-Cell Homing with or without a scaffold
AUGS, IUGA, ICS 2009: Chemokines, myoblasts, and fibroblasts
Do you think that this treatment will be available on the market in the near to moderately near future?
Which of these alternatives is/are financially feasible?
Commercially proliferated autologous stem cells
Regenerated donor stem cells
Stem cell homing
Tissue and organ engineering
What’s the Price / Value proposition to the patient ?
Cellular: regenerate or signal to scaffold
Bioactive, conductive, remodeling tissues
Inert, inactive, permanent materials
Volume & Value
(Does or how does previous collagen affect future anti-incontinence surgery results?)